Accelerated Worsening in Serum Neurofilament Light Chain Levels and Multiple Sclerosis Functional Composite in Women with MS after Menopause

被引:0
|
作者
Silverman, Hannah [1 ]
Bostrom, Alan [2 ,3 ]
Lazar, Ann [2 ,3 ]
Gomez, Refujia [1 ]
Santaniello, Adam [1 ]
Renschen, Adam [1 ]
Harms, Meagan [1 ]
Cooper, Tiffany [1 ]
Lincoln, Robin [1 ]
Poole, Shane [1 ]
Henry, Roland [1 ]
Oksenberg, Jorge [1 ]
Hauser, Stephen [1 ]
Cree, Bruce A. C. [1 ]
Bove, Riley [1 ]
机构
[1] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA USA
[2] Univ Calif San Francisco, Div Oral Epidemiol, Dept Prevent & Restorat Dent Sci, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, Div Biostat, San Francisco, CA USA
关键词
D O I
10.1212/WNL.0000000000203215
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S9.009
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis
    Bsteh, Gabriel
    Berek, Klaus
    Hegen, Harald
    Buchmann, Arabella
    Voortman, Margarete M.
    Auer, Michael
    Wurth, Sebastian
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Khalil, Micheal
    Berger, Thomas
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [42] Basal levels of serum neurofilament light in normal aging and multiple sclerosis patients
    Gasque Rubio, R.
    Villar, L. M.
    Cubas Nunez, L.
    Laiz, B.
    Quintanilla Bordas, C.
    Carratala Bosca, S.
    Gil-Perotin, S.
    Perez Miralles, F.
    Alcala, C.
    Castillo Villalba, J.
    Casanova Estruch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 525 - 525
  • [43] Neurofilament light chain in human blood is a predictor of disease worsening in relapsing-remitting multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Haring, D. A.
    Barro, C.
    Kappos, L.
    Leppert, D.
    Tomic, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 298 - 299
  • [44] CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
    Bhan, Alok
    Jacobsen, Cecilie
    Dalen, Ingvild
    Bergsland, Niels
    Zivadinov, Robert
    Alves, Guido
    Myhr, Kjell-Morten
    Farbu, Elisabeth
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (04)
  • [45] Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis
    Pauwels, Ayla
    Van Schependom, Jeroen
    Devolder, Lindsay
    Van Remoortel, Ann
    Nagels, Guy
    Bjerke, Maria
    D'hooghe, Marie B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (11) : 1685 - 1696
  • [46] Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs
    Monreal, Enric
    Ignacio Fernandez-Velasco, Jose
    Garcia-Sanchez, Maria Isabel
    Sainz de la Maza, Susana
    Llufriu, Sara
    Alvarez-Lafuente, Roberto
    Casanova, Bonaventura
    Comabella, Manuel
    Ramio-Torrenta, Lluis
    Martinez-Rodriguez, Jose Enrique
    Brieva, Luis
    Saiz, Albert
    Eichau, Sara
    Maria Cabrera-Maqueda, Jose
    Villarrubia, Noelia
    Espino, Mercedes
    Perez-Miralles, Francisco
    Montalban, Xavier
    Tintore, Mar
    Quiroga-Varela, Ana
    Inmaculada Dominguez-Mozo, Maria
    Rodriguez-Jorge, Fernando
    Luis Chico-Garcia, Juan
    Lourido, Daniel
    Carlos Alvarez-Cermeno, Jose
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Maria Villar, Luisa
    JAMA NEUROLOGY, 2023, 80 (04) : 397 - 403
  • [47] Alemtuzumab reduces serum neurofilament light chain levels in relapsing-remitting multiple sclerosis patients from the CARE-MS I study
    Kuhle, J.
    Daizadeh, N.
    Barro, C.
    Michalak, Z.
    Godin, J.
    Shankara, S.
    Samad, T. A.
    Jacobs, A.
    Chung, L.
    Roesch, N.
    Kaiser, C.
    Havari, E.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 994 - 995
  • [48] Serum Neurofilament Light Chain Levels Correlate with Disease Characteristics in Patients with Relapsing-Remitting Multiple Sclerosis from CARE-MS I
    Kuhle, Jens
    Daizadeh, Nadia
    Barro, Christian
    Michalak, Zuzanna
    Leppert, David
    Godin, Jean
    Shankara, Srinivas
    Samad, Tarek
    Jacobs, Alan
    Chung, Luke
    Roesch, Nora
    Kaiser, Carina
    Havari, Evis
    Kappos, Ludwig
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 30 - 30
  • [49] Serum neurofilament light chain as a predictive marker in patients after first demyelinating event suggestive of multiple sclerosis
    Benova, B.
    Barro, C.
    Andelova, M.
    Uher, T.
    Michalak, Z.
    Tyblova, M.
    Kucerova, K.
    Hrnciarova, T.
    Vaneckova, M.
    Kadrnozkova, L.
    Motyl, J.
    Havrdova, E.
    Kuhle, J.
    Horakova, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 450 - 450
  • [50] Serum Neurofilament Light Chain and Glial Fibrillary Acid Protein in Patients With Multiple Sclerosis
    Ayrignac, Xavier
    Maceski, Aleksandra Maleska
    Carra-Dalliere, Clarisse
    Charif, Mahmoud
    Catteau, Cyndi
    Ginestet, Nelly
    Prin, Pauline
    Corti, Lucas
    Pinna, Frederic
    Lehmann, Sylvain
    Labauge, Pierre
    NEUROLOGY, 2019, 92 (15)